School of Biological Sciences and Edinburgh Medical School: Biomedical Sciences , University of Edinburgh , The King's Buildings, Edinburgh EH9 3BF , United Kingdom.
EaStCHEM School of Chemistry , University of Edinburgh , Edinburgh EH9 3FJ , United Kingdom.
Anal Chem. 2019 May 7;91(9):5582-5590. doi: 10.1021/acs.analchem.8b03842. Epub 2019 Apr 18.
α-Synuclein fibrils are considered a hallmark of Parkinson's disease and other synucleinopathies. However, small oligomers that formed during the early stages of α-synuclein aggregation are thought to be the main toxic species causing disease. The formation of α-synuclein oligomers has proven difficult to follow, because of the heterogeneity and transient nature of the species formed. Here, a novel bead-based aggregation assay for monitoring the earliest stages of α-synuclein oligomerization, α-Synuclein-Confocal Nanoscanning (ASYN-CONA), is presented. The α-synuclein A91C single cysteine mutant is modified with a trifunctional chemical tag, which allows simultaneous fluorescent labeling with a green dye (tetramethylrhodamine, TMR) and attachment to microbeads. Beads with bound TMR-labeled α-synuclein are then incubated with a red dye (Cy5)-labeled variant of α-synuclein A91C, and EtOH (20%) to induce aggregation. Aggregation is detected by confocal scanning imaging, below the equatorial plane of the beads, which is known as the CONA technique. On-bead TMR-labeled α-synuclein and aggregated Cy5-labeled α-synuclein from the solution are quantitatively monitored in parallel by detection of fluorescent halos or "rings". α-Synuclein on-bead oligomerization results in a linear increase of red bead ring fluorescence intensity over a period of 5 h. Total internal reflection fluorescence microscopy was performed on oligomers cleaved from the beads, and it revealed that (i) oligomers are sufficiently stable in solution to investigate their composition, consisting of 6 ± 1 monomer units, and (ii) oligomers containing a mean of 15 monomers bind Thioflavin-T. Various known inhibitors of α-synuclein aggregation were used to validate the ASYN-CONA assay for drug screening. Baicalein, curcumin, and rifampicin showed concentration-dependent inhibition of the α-synuclein aggregation and the IC (the concentration of the compound at which the maxiumum intensity was reduced by one-half) were calculated.
α-突触核蛋白纤维被认为是帕金森病和其他突触核蛋白病的标志。然而,在 α-突触核蛋白聚集的早期形成的小寡聚体被认为是导致疾病的主要毒性物种。由于形成的物种的异质性和瞬态性质,α-突触核蛋白寡聚体的形成一直难以跟踪。在这里,提出了一种用于监测 α-突触核蛋白寡聚化最早阶段的新型基于珠的聚集测定法,即α-突触核蛋白共焦纳米扫描(ASYN-CONA)。α-突触核蛋白 A91C 单半胱氨酸突变体用三功能化学标签修饰,该标签允许与绿色染料(四甲基罗丹明,TMR)同时荧光标记,并与微珠结合。然后,将与 TMR 标记的 α-突触核蛋白结合的珠与红色染料(Cy5)标记的 α-突触核蛋白 A91C 变体和乙醇(20%)一起孵育以诱导聚集。通过共焦扫描成像在珠的赤道平面以下检测到聚集,这就是众所周知的 CONA 技术。通过检测荧光晕或“环”,可以同时定量监测溶液中带 TMR 标记的 α-突触核蛋白和聚集的 Cy5 标记的 α-突触核蛋白。珠上的 α-突触核蛋白寡聚化导致红色珠环荧光强度在 5 小时的时间段内线性增加。对从珠上切割的寡聚物进行全内反射荧光显微镜检查,结果表明:(i)寡聚物在溶液中足够稳定,可以研究其组成,由 6±1 个单体单元组成;(ii)含有 15 个单体的寡聚物结合 Thioflavin-T。还使用了各种已知的 α-突触核蛋白聚集抑制剂来验证 ASYN-CONA 测定法用于药物筛选。白杨素、姜黄素和利福平显示出浓度依赖性抑制 α-突触核蛋白聚集的作用,并计算了 IC(使最大强度降低一半时化合物的浓度)。